India's Sun Pharmaceutical, looking to cut back its manufacturing operations since its buyout of Ranbaxy Laboratories, will sell a formulation plant in Bryan, OH, to Nostrum Laboratories. The companies are keeping terms of the deal under wraps. Sun had picked the plant up in 2005 from Valeant Pharmaceuticals ($VRX). It is the second plant that Sun has indicated it will dispose of. In September, the company said it was looking at closing a plant in Tipperary, Ireland, with 100 employees. Release | More